Navigation Links
Boston Scientific Provides Update on Involuntary Selling of Its Stock by Co-Founders
Date:10/13/2008

This press release contains forward-looking statements within the meaning of Section 21E of the Securities Exchange Act of 1934. Forward-looking statements may be identified by words like "anticipate," "expect," "project," "believe," "plan," "estimate," "intend" and similar words. These forward-looking statements are based on our beliefs, assumptions and estimates using information available to us at the time and are not intended to be guarantees of future events or performance. These forward-looking statements include, among other things, statements regarding potential additional automatic selling and our long-term prospects. If our underlying assumptions turn out to be incorrect, or if certain risks or uncertainties materialize, actual results could vary materially from the expectations and projections expressed or implied by our forward-looking statements. These factors, in some cases, have affected and in the future (together with other factors) may cause actual results to differ materially from those contemplated by the statements expressed in this press release. As a result, readers are cautioned not to place undue reliance on any of our forward-looking statements.

Factors that may cause such differences include, among other things: future economic, competitive, reimbursement and regulatory conditions; new product introductions; demographic trends; intellectual property; litigation; financial market conditions; and, future business decisions made by us and our competitors. All of these factors are difficult or impossible to predict accurately and many of them are beyond our control. For a further list and description of these and other important risks and uncertainties that may affect our future operations, see Part I, Item 1A - Risk Factors in our most recent Annual Report on Form 10-K filed with the Securities and Exchange Commission, which we may update in Part II, Item 1A - Risk Factors in Quarterly Reports on Form 10-Q we have filed or will
'/>"/>

SOURCE Boston Scientific
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related biology technology :

1. Boston Scientific to Explore Sale of Cardiac Surgery and Vascular Surgery Businesses
2. Vicus Therapeutics to Present at the 234th American Chemical Society National Meeting in Boston, MA
3. Boston Scientific Amends Credit Facility and Prepays $1 Billion on Loan
4. Boston Scientific to Participate in the Bear Stearns 20th Annual Healthcare Conference
5. Revolutionary Genomics Research Group Opens Boston Office; Provides DNA Evidence in Workers Comp Cases
6. Boston Scientific Announces Election of Ray Elliott to Its Board of Directors
7. Alliance for Medical Devices, Instrumentation and Diagnostics formed between Fraunhofer Center for Manufacturing Innovation and Boston University
8. Boston Scientific Releases Remote Monitoring Data from its Wireless LATITUDE(R) Patient Management System
9. Genzyme Begins Major Expansion of Boston Manufacturing Facility
10. New Scientists Boost Disease-based Research at Boston Biomedical Research Institute
11. Boston Scientific to Webcast Conference Call Discussing Third Quarter Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/16/2009)... 16 WaferGen Biosystems, Inc. (OTC Bulletin ... analysis systems, today announced that it will be ... service for gene-expression profiling using its SmartChip(TM) Real-Time ... the most comprehensive human microRNA panel of 885 ... SmartChip service offers customers the use of its ...
(Date:12/16/2009)... by swimming , ... Argonne, ... Department of Energy’s (DOE) Argonne National Laboratory and Northwestern University, ... when suspended in a solution, providing insights for design of ... are a million times more massive than the bacteria,” said ...
(Date:12/16/2009)... Dec. 16 /PRNewswire/ -- ... life sciences industry and an active venture capital ... Indiana State Teachers Retirement Fund, Indiana University, Purdue ... Fairbanks Foundation, and Credit Suisse today announced the ... venture capital fund of funds. ,, Organized through ...
(Date:12/16/2009)... company,s revenues increase 22% for fiscal 2009; on ... , TORONTO, Dec. 16 /PRNewswire-FirstCall/ - Microbix Biosystems ... and biological technologies, today reported financial results for ... year ended September 30, 2009, Microbix reported revenues ... same period in 2008. For fourth-quarter 2009, the ...
Breaking Biology Technology:WaferGen to Launch Human MicroRNA Panel for Gene-Expression Profiling of 885 MicroRNA for Its Service Using the SmartChip(TM) Real-Time PCR System 2WaferGen to Launch Human MicroRNA Panel for Gene-Expression Profiling of 885 MicroRNA for Its Service Using the SmartChip(TM) Real-Time PCR System 3WaferGen to Launch Human MicroRNA Panel for Gene-Expression Profiling of 885 MicroRNA for Its Service Using the SmartChip(TM) Real-Time PCR System 4Argonne Scientists Use Bacteria to Power Simple Machines 2Argonne Scientists Use Bacteria to Power Simple Machines 3Indiana Industry, University and Community Leaders Capitalize on Next Generation of State's Life Sciences Growth 2Indiana Industry, University and Community Leaders Capitalize on Next Generation of State's Life Sciences Growth 3Indiana Industry, University and Community Leaders Capitalize on Next Generation of State's Life Sciences Growth 4Indiana Industry, University and Community Leaders Capitalize on Next Generation of State's Life Sciences Growth 5Microbix' Pipeline Set To Reach Milestones In 2010 2Microbix' Pipeline Set To Reach Milestones In 2010 3Microbix' Pipeline Set To Reach Milestones In 2010 4Microbix' Pipeline Set To Reach Milestones In 2010 5Microbix' Pipeline Set To Reach Milestones In 2010 6Microbix' Pipeline Set To Reach Milestones In 2010 7Microbix' Pipeline Set To Reach Milestones In 2010 8
... will bike down the California coast to ... and help those affected by arthritis, SAN FRANCISCO, Sept. ... annual Amgen California Coast Classic,Bike Tour on Saturday, September 29 ... over eight days, aim to raise more,than $1.3 million this ...
... Campbell Alliance, the leading,management consulting firm ... announced that Ben Bonifant, Vice President and ... a panel discussion,at the Pharmaceutical Strategic Alliances ... will be held September 25-27, 2007 at,The ...
... Sept. 21 Roche has,advised Maxygen, Inc. (Nasdaq: ... further clinical development of MAXY-alpha, also known as R7025.,MAXY-alpha ... C and,Hepatitis B virus infections and is licensed to ... indicate that an,unexpected reduction of the pharmacodynamic and pharmacokinetic ...
Other Biology Technology:More Than 230 Cyclists to Ride in Amgen California Coast Classic Bike Tour to Raise $1.3 Million for Arthritis Foundation 2Campbell Alliance to Moderate Senior-Level Panel Discussion at Windhover Pharmaceutical Strategic Alliances Conference 2Campbell Alliance to Moderate Senior-Level Panel Discussion at Windhover Pharmaceutical Strategic Alliances Conference 3Maxygen Announces Hold on MAXY-alpha Development Program 2Maxygen Announces Hold on MAXY-alpha Development Program 3
(Date:12/16/2009)... our planet for more than 4 billion years before ... as many eons more. That suggests they may have ... Aviv University bacteria expert Prof. Eshel Ben-Jacob of the ... grounded in the study of bacteria, presents compelling evidence ... people should not automatically opt for the swine flu ...
(Date:12/16/2009)... School of Medicine researcher will lead the coordinating center ... in the field of stem cell research. Michael L. ... chosen by the National Heart, Lung and Blood Institute ... national experts, which will be called the NHLBI Progenitor ... by a $30 million grant over seven years. ...
(Date:12/16/2009)... SUNNYVALE, Calif., Dec. 1 GestureTek ... CUBE, Release 3.0 - a turnkey, portable, ... for advertising, exhibits, entertainment and touring promotions. ... dozens of patents in camera-enabled gesture recognition ... systems. ,, Guaranteed for quality, the CUBE ...
Breaking Biology News(10 mins):Bacteria wouldn't opt for a swine flu shot 2Bacteria wouldn't opt for a swine flu shot 3University of Maryland School of Medicine receives $30 million to coordinate stem cell consortium 2University of Maryland School of Medicine receives $30 million to coordinate stem cell consortium 3GestureTek Unveils The CUBE V3 Portable, Plug and Play Interactive Projection Display System for Advertising and Exhibits 2GestureTek Unveils The CUBE V3 Portable, Plug and Play Interactive Projection Display System for Advertising and Exhibits 3New Antimicrobial Webs Sterilize Medical Implants for 14 Days 14046 1New Antimicrobial Webs Sterilize Medical Implants for 14 Days 14046 2Universal Medical Systems of Ohio Introduces Charlie Worlds First Portable Battery Operated Multi Slice CT Scanner for Pets 57156 1Universal Medical Systems of Ohio Introduces Charlie Worlds First Portable Battery Operated Multi Slice CT Scanner for Pets 57156 2Universal Medical Systems of Ohio Introduces Charlie Worlds First Portable Battery Operated Multi Slice CT Scanner for Pets 57156 3Universal Medical Systems of Ohio Introduces Charlie Worlds First Portable Battery Operated Multi Slice CT Scanner for Pets 57156 4Second U S Egypt Collaborative Clinical Study Blocked by New York State Department of Health 28NYSDOH 29 This Time on Complications of Diabetes 14045 1Second U S Egypt Collaborative Clinical Study Blocked by New York State Department of Health 28NYSDOH 29 This Time on Complications of Diabetes 14045 2Second U S Egypt Collaborative Clinical Study Blocked by New York State Department of Health 28NYSDOH 29 This Time on Complications of Diabetes 14045 3
... of researchers working with colleagues from the Botswana National ... cattle were brought to southern Africa and from where. ... ago was excavated from a site at Toteng, located ... dated by the Accelerator Mass Spectrometry (AMS) radiocarbon technique, ...
... systemWith their latest discovery, researchers have significantly advanced ... from constant and potentially destructive changes in gene ... month's Nature Structural & Molecular Biology, the research ... to disease, and the ability to side-step it ...
... announced that it has achieved GeneChip-compatible TM ... , GeneChip® microarray platform and that it has ... with a broad spectrum of software solutions for ... provider, Genomatix is committed to seamlessly integrating its ...
Other Biology News:Study provides insight into cellular defenses against genetic mutation 2Study provides insight into cellular defenses against genetic mutation 3Study provides insight into cellular defenses against genetic mutation 4